Your browser doesn't support javascript.
loading
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
Inzaule, Seth C; Hamers, Raph L; Noguera-Julian, Marc; Casadellà, Maria; Parera, Mariona; Kityo, Cissy; Steegen, Kim; Naniche, Denise; Clotet, Bonaventura; Rinke de Wit, Tobias F; Paredes, Roger.
Afiliación
  • Inzaule SC; Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands.
  • Hamers RL; Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands
  • Noguera-Julian M; Infectious Diseases Service & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain; Universitat de Vic-Universitat Central de Catalunya, Vic, Spain.
  • Casadellà M; Infectious Diseases Service & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
  • Parera M; Infectious Diseases Service & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
  • Kityo C; Joint Clinical Research Centre, Kampala, Uganda.
  • Steegen K; Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa; National Health Laboratory Service, Johannesburg, South Africa.
  • Naniche D; ISGlobal, Barcelona Institute for Global Health Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Clotet B; Infectious Diseases Service & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain; Universitat de Vic-Universitat Central de Catalunya, Vic, Spain.
  • Rinke de Wit TF; Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands.
  • Paredes R; Infectious Diseases Service & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain; Universitat de Vic-Universitat Central de Catalunya, Vic, Spain.
Lancet HIV ; 5(11): e638-e646, 2018 11.
Article en En | MEDLINE | ID: mdl-30282603
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Inhibidores de la Transcriptasa Inversa / Fármacos Anti-VIH / Farmacorresistencia Viral Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Lancet HIV Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Inhibidores de la Transcriptasa Inversa / Fármacos Anti-VIH / Farmacorresistencia Viral Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Lancet HIV Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos